Bausch Health Cos. Inc., the Canadian parent company of Bausch & Lomb Inc., will acquire certain assets of the bankrupted Synergy Pharmaceuticals Inc. for $195 million. A hearing to approve the sale is scheduled for March 1. “As we continue ...

Tagged with: acquisitions bausch & lomb bausch health synergy pharmaceuticals

Shares of Bausch Health Cos. Inc., Bausch & Lomb Inc.’s Canadian parent company, were down more than 8 percent Wednesday after the health care product company reported a fourth-quarter loss of $344 million. For the quarter ended Dec. 31, Bausch ...

Tagged with: bausch & lomb bausch health Earnings

Bausch Health Cos. Inc. is planning a major expansion to its contact lens manufacturing capacity in Rochester and Waterford, Ireland, the company announced Tuesday. The company did not disclose the investment amount. Bausch Health, the parent company of Bausch & ...

Tagged with: bausch & lomb bausch health

Bausch & Lomb Inc. parent, Bausch Health Cos. Inc., on Tuesday reported a decline in sales and a net loss in the second quarter, but the results were better than analysts had expected. Bausch Health, formerly Valeant Pharmaceuticals International Inc., ...

Tagged with: bausch & lomb bausch health bhc Earnings valeant

Bausch & Lomb Inc. parent Valeant Pharmaceuticals International Inc. has changed its name and last week began trading under a new ticker symbol on the New York Stock Exchange. Valeant’s new moniker, Bausch Health Cos. Inc. (NYSE: BHC), will help ...

Tagged with: bausch & lomb bausch health valeant